COVID-19:争取疫苗的竞赛
L Hayley Burgess1, Jason J Braithwaite2,3, Emily Singleton2,4
1HCA Healthcare, Clinical Operations Group, Nashville, TN.
HCA healthcare journal of medicine
|July 10, 2023
概括
由于COVID-19的流行,迫切需要疫苗. 战争速度行动加速了开发,产生了Moderna和Pfizer的高效疫苗,但公众的信心仍然是一个挑战.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行病导致全球数百万病例和死亡.
- 传统的疫苗开发时间表很长 (10+年),进入市场的可能性很低.
- 在这些努力之前,没有有效的冠状病毒疫苗在商业上可用.
研究的目的:
- 加速开发和提供安全有效的COVID-19疫苗.
- 为了解决迫切需要疫苗以减轻大流行病的全球影响.
- 评估主要候选疫苗的疗效和安全性.
主要方法:
- 形速度行动协调政府支持,并行临床试验和早期制造降低风险.
- 美国食品和药物管理局 (FDA) 实时安全性和有效性数据评估.
- 对主要候选疫苗的疫苗疗效率的监测.
主要成果:
- 两种领先的候选疫苗显示出高效率:Moderna的94.1%和Pfizer的95.0%.
- 与历史平均值相比,开发时间表被显著压缩.
- 尽管高效,但国家调查显示公众信心较低 (<50%的愿意接种疫苗).
结论:
- 针对COVID-19的加速疫苗开发在生产高效候选人方面取得了成功.
- 实现群体免疫需要高的疫苗疗效 (70-80%) 和疫苗接种率 (70-80%).
- 需要大量的公众教育和宣传工作,以建立对疫苗的信心,并实现人口的保护.
关键词:
在 COVID-19 疫情中,关于COVID-19疫苗的使用情况这就是SARS-CoV-2病毒.冠状病毒感染 冠状病毒感染这是一种流行病流行病.免疫接种 免疫接种 免疫接种传递 RNA 的信使 RNA.流行病是一种流行病.患者安全 患者安全疫苗,疫苗的使用情况.病毒疫苗/不良反应更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.6K
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.6K
相关概念视频
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Cancer Vaccines
419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419
Development of Immunocompetence
357
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
357
Vaccinations
44.8K
Overview
44.8K
Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
